Oxcarbazepine Tablet
Product Images NDC 68382-692

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68382-692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (79f3f911 87ac 44ee Ad84 76e15048542c 01)

Chemical structure of oxcarbazepine showing a bicyclic system with two phenyl rings attached to a seven-membered ring with a ketone (C=O) and an amide (CONH2) functional group.*

FDA Label Image

Figure (79f3f911 87ac 44ee Ad84 76e15048542c 02)

A line graph showing exit rate over time on trial from Day 2 to Day 11 in days, comparing two treatment groups: Oxcarbazepine (solid line) and Placebo (dashed line). The y-axis represents exit rate from 0 to 1.0, and the x-axis represents time in days with labels from Day 2 8 am to Day 11 8 am. The graph includes a statistical notation of log-rank test p-value = 0.0001.*

FDA Label Image

Figure (79f3f911 87ac 44ee Ad84 76e15048542c 03)

A Kaplan-Meier survival curve showing seizure rate over time in days from first dose to first seizure. The graph compares two treatment groups: oxcarbazepine (solid line) and placebo (dotted line). The y-axis represents seizure rate from 0 to 1, and the x-axis shows days from 0 to 140. A log-rank test p-value of 0.046 is noted, indicating a statistical comparison between groups.*

FDA Label Image

Figure (79f3f911 87ac 44ee Ad84 76e15048542c 04)

A stepwise line graph showing exit rate over time in days up to 130 days, comparing two treatment groups labeled 'HIGH' (solid line) and 'LOW' (dashed line). The vertical axis represents exit rate, and a log-rank test p-value of 0.0001 is noted on the chart.*

FDA Label Image

Figure (79f3f911 87ac 44ee Ad84 76e15048542c 05)

A Kaplan-Meier survival curve chart illustrating exit rate over time in days, comparing two treatment groups labeled 'HIGH' and 'LOW'. The x-axis shows time to exit (0 to 130 days), and the y-axis shows exit rate (0 to 1.0). The HIGH group is represented by a solid line, and the LOW group by a dotted line. The chart includes a log-rank test p-value of 0.0001 indicating statistical comparison between groups.*

FDA Label Image

150mg Container Label (79f3f911 87ac 44ee Ad84 76e15048542c 06)

Oxcarbazepine Tablets USP 150 mg oral tablets packaging label. The label shows a pair of oval, film-coated tablets, one imprinted with '5 91'. The package contains 100 tablets and is labeled for prescription use only. The product is manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

150mg Carton Label (79f3f911 87ac 44ee Ad84 76e15048542c 07)

Packaging label for Oxcarbazepine Tablets USP 150 mg oral tablets by Zydus Pharmaceuticals (USA) Inc. The label shows the NDC 68382-691-30 and indicates the package contains 100 tablets in unit-dose blisters (10 x 10). The label includes images of two oblong, scored yellow tablets. Storage instructions note 20° to 25°C, and usual dosage information refers to the package insert.*

FDA Label Image

300mg Container Label (79f3f911 87ac 44ee Ad84 76e15048542c 08)

Label for Oxcarbazepine Tablets, USP 300 mg oral tablets, showing two oblong yellow tablets with imprint '692'. The label includes the NDC code 68382-692-01, pharmacist dispensing instructions, and notes the product is manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. The package contains 100 tablets, prescription only.*

FDA Label Image

300mg Carton Label (79f3f911 87ac 44ee Ad84 76e15048542c 09)

Packaging label for Oxcarbazepine Tablets, USP, 300 mg oral tablets. The label includes images of the oval, tan tablets imprinted with '6 92'. The product is labeled as a unit dose package containing 100 tablets (10 x 10 unit-dose), manufactured by Cadila Healthcare Ltd., Baddi, India, and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. Storage instructions and usual dosage guidance to consult package insert are provided. The label also displays Rx only and the Zydus Pharmaceuticals logo.*

FDA Label Image

600mg Container Label (79f3f911 87ac 44ee Ad84 76e15048542c 10)

Oxcarbazepine Tablets, USP 600 mg oral tablets label showing the product name, strength, and images of two yellowish oval tablets imprinted with '6' and '93'. Packaging indicates 100 tablets in the container, manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes storage instructions and a pharmacist dispensing note.*

FDA Label Image

600mg Carton Label (79f3f911 87ac 44ee Ad84 76e15048542c 11)

Oxcarbazepine Tablets, USP 600 mg oral tablet packaging carton. The label shows the dosage strength prominently, the tablet image with imprint '6 93', indication to see the package insert for dosage, storage instructions, quantity of 100 tablets (10 x 10 unit-dose), and is labeled for prescription use only. Manufactured by Cadila Healthcare Ltd., distributed by Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.